Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital-Reference-Cited by-同舟云学术

Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital

Published:2017-05-30 Issue:1 Volume:16 Page:
ISSN:1476-0711
Container-title:Annals of Clinical Microbiology and Antimicrobials
language:en
Short-container-title:Ann Clin Microbiol Antimicrob

Author:

Chastain Daniel B.^ORCID,Ngando Ijang,Bland Christopher M.,Franco-Paredes Carlos,Hawkins W. Anthony

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12941-017-0217-x.pdf

Reference14 articles.

1. Kumar S, Dave A, Wolf B, Lerma EV. Urinary tract infections. Dis Mon. 2015;61(2):45–59.

2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;118(Suppl 1A):5S–13S.

3. Turnidge JD. Subcommittee on antimicrobial susceptibility testing of the clinical and laboratory standards institute. Cefazolin and enterobacteriaceae: rational for revised susceptibility testing breakpoints. Clin Infect Dis. 2011;52(7):917–24.

4. Turnidge JD, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev. 2007;20(3):391–408.

5. Hooton TM, Scholes D, Gupta K, et al. Amoxicillin–clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA. 2005;293:949–55.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmented antibacterial activity of cefazolin with silver nanoparticles against Staphylococcus aureus and Escherichia coli;Journal of Drug Delivery Science and Technology;2023-08

2. Retrospective Comparison of Cefdinir, Cephalexin, and Sulfamethoxazole-Trimethoprim in the Treatment of Outpatient Pediatric Urinary Tract Infections;Clinical Pediatrics;2022-07-21

3. The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections;Diagnostic Microbiology and Infectious Disease;2021-10

4. Virulence Genes Profile and Antimicrobial Susceptibility of Community-Acquired Bacterial Urinary Tract Infections in a Brazilian Hospital;Current Microbiology;2021-09-14

5. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of “Bad Bugs, Few Drugs”;International Journal of Antimicrobial Agents;2020-10